Matt Britz
Directeur Général chez Affyimmune Therapeutics, Inc.
Postes actifs de Matt Britz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Directeur Général | 19/03/2024 | - |
| Directeur des opérations | 01/01/2022 | - | |
| Corporate Officer/Principal | 01/06/2021 | 01/01/2022 | |
| President | 01/06/2021 | 19/03/2024 |
Historique de carrière de Matt Britz
Formation de Matt Britz
| University of Massachusetts | Undergraduate Degree |
| Washington University in St. Louis | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Bourse
- Insiders
- Matt Britz
- Expérience
